Published online Jun 28, 2025. doi: 10.4329/wjr.v17.i6.108247
Revised: April 19, 2025
Accepted: May 26, 2025
Published online: June 28, 2025
Processing time: 78 Days and 23.6 Hours
Dual-phenotype hepatocellular carcinoma (HCC) is a relatively new subtype of HCC. Studies have shown that in the context of chronic hepatitis, liver cirrhosis, and other liver conditions, some intrahepatic cholangiocarcinomas (ICCs) exhibit an enhancement pattern similar to that of HCC. Both dual-phenotype HCC (DPHCC) and ICC can express biliary markers, making imaging and pathology differentiation difficult. Currently, radiomics is widely used in the differentiation, clinical staging, and prognosis assessment of various diseases. Radiomics can effectively differentiate DPHCC and ICC preoperatively.
To evaluate the value of radiomics in the differential diagnosis of DPHCC and ICC and to validate its clinical applicability
In this retrospective study, the data of 53 DPHCC patients and 124 ICC patients were collected retrospectively and randomly divided into training and testing sets at a ratio of 7: 3. After delineation of regions of interest and feature extraction and selection, radiomics models were constructed. Receiver operating characteristic curve analysis was conducted to calculate the area under the curve (AUC) for each model. The AUC values of radiologists with and without assistance from the model were also assessed.
In the training set, the AUC value of the radiomic model was the highest, and the combined model and the radiomic model had similar AUC (P > 0.05); the differences in the AUC values between the combined model and the clinical-sign model was statistically significant (P < 0.05). In the testing set, the AUC value of the combined model was the highest, and the differences in the AUC values between the combined model and the clinical-sign model was statistically significant (P < 0.05). With model assistance, the AUC values of Doctor D (10 years of experience in abdominal imaging diagnosis) and Doctor E (5 years of experience in abdominal imaging diagnosis) both increased.
Radiomics can differentiate DPHCC and ICC, and with assistance from the developed model, the accuracy of less experienced doctors in the differential diagnosis of these two diseases can be improved.
Core Tip: In the present study, the clinical and imaging data of 53 dual-phenotype hepatocellular carcinoma (DPHCC) patients and 124 intrahepatic cholangiocarcinoma (ICC) patients were collected, the regions of interest were delineated slice by slice, and relevant information was extracted to construct a clinical-sign model, a radiomic model, and a combined model. Subsequently, the performance of the predictive models was evaluated to explore their clinical applicability. The study found that radiomics can effectively differentiate DPHCC and ICC preoperatively, and with assistance from the developed model, the accuracy of less experienced doctors in the differential diagnosis of these two diseases can be improved.